查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1665265

Dura 替代品市场机会、成长动力、产业趋势分析与 2025 - 2034 年预测

Dura Substitutes Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年全球硬脊膜替代品市场规模达到 2.142 亿美元，预计 2025 年至 2034 年期间将以 5.4% 的年复合成长率(CAGR) 强劲增长。这一增长轨迹受到医疗技术的不断进步、对微创手术的偏好日益增加、对神经外科认识的不断提高人口的扩大以及老龄化人口的扩大。总的来说，这些因素推动了 Dura 替代品在各种医疗应用中的采用。

Dura 替代品市场 - IMG1

生物材料和手术技术的创新大大提高了硬脑膜替代品的性能和品质。现代材料旨在提高生物相容性、耐用性和吸收性，正在提高手术效果并巩固硬脑膜替代品作为神经外科实践中必不可少的组成部分的作用。随着医疗技术的不断发展，对先进的硬脑膜替代品的需求将会上升，进一步加速市场成长。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 2.142亿美元
预测值 3.571亿美元
复合年增长率 5.4%

根据产品类型，市场分为生物和合成硬脑膜替代品。生物硬脑膜替代品，来自胶原蛋白和动物组织等天然来源，预计年复合增长率为 5.1%，到 2034 年将达到 2.326 亿美元。它们与身体的无缝结合确保了一致的需求，并使其成为外科手术应用中可靠的解决方案。

市场也按应用进行细分，包括神经外科、脊椎外科、创伤和事故修復、术后修復等。预计神经外科领域将达到显着增长，预计复合年增长率为 5.5%，到 2034 年将达到 1.559 亿美元。这些材料对于修復硬脑膜是必不可少的，增强了其在神经外科治疗中的关键作用。

美国硬膜替代品市场在 2024 年的价值为 7,700 万美元，预计到 2034 年将以 5% 的复合年增长率成长。这些进步有助于改善手术效果并加速患者康復，进一步支持该地区的市场扩张。

目录

第 1 章：方法论与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业衝击力
    • 成长动力
      • 神经系统疾病盛行率不断上升
      • 手术技术的进步
      • 提高外科手术认知和采用率
      • 微创手术需求不断成长
    • 产业陷阱与挑战
      • 硬脑膜替代品成本高
      • 新兴市场产品供应有限
  • 成长潜力分析
  • 监管格局
  • 技术格局
  • 差距分析
  • 波特的分析
  • PESTEL 分析
  • 未来市场趋势
  • 价值链分析

第四章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 策略仪表板

第 5 章：市场估计与预测：按产品类型，2021 年至 2034 年

  • 主要趋势
  • 生物硬脑膜替代物
  • 合成硬脑膜替代物

第六章：市场估计与预测：按材料，2021 – 2034 年

  • 主要趋势
  • 胶原蛋白类
  • 聚合物
  • 其他材料

第 7 章：市场估计与预测：按应用，2021 年至 2034 年

  • 主要趋势
  • 神经外科
  • 脊椎手术
  • 创伤/意外
  • 术后修復
  • 其他应用

第 8 章：市场估计与预测：依最终用途，2021 年至 2034 年

  • 主要趋势
  • 医院
  • 门诊手术中心
  • 其他最终用户

第 9 章：市场估计与预测：按地区，2021 年至 2034 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第十章：公司简介

  • ACERA SURGICAL
  • B. Braun
  • Baxter
  • Bennett
  • Biosynth
  • Cook Medical
  • DePuy Synthes
  • GUNZE
  • INTEGRA
  • Medprin
  • Medtronic
  • Natus
  • Severn Healthcare Technologies
  • Stryker
  • GORE
简介目录
Product Code: 12745

The Global Dura Substitutes Market reached USD 214.2 million in 2024 and is projected to experience robust growth at a compound annual growth rate (CAGR) of 5.4% from 2025 to 2034. This growth trajectory is propelled by ongoing advancements in medical technologies, the increasing preference for minimally invasive procedures, rising awareness of neurosurgical treatments, and the expanding aging population. Collectively, these factors are driving the adoption of Dura substitutes in various medical applications.

Dura Substitutes Market - IMG1

Innovations in biomaterials and surgical techniques are significantly enhancing the performance and quality of dura substitutes. Modern materials, designed for improved biocompatibility, durability, and absorbability, are elevating surgical outcomes and solidifying the role of dura substitutes as essential components in neurosurgical practices. As medical technology continues to evolve, the demand for advanced dura substitutes is poised to rise, further accelerating market growth.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$214.2 Million
Forecast Value$357.1 Million
CAGR5.4%

By product type, the market is categorized into biological and synthetic dura substitutes. Biological dura substitutes, derived from natural sources like collagen and animal tissues, are anticipated to grow at a CAGR of 5.1%, reaching USD 232.6 million by 2034. These substitutes offer exceptional biocompatibility and reduce risks associated with immune responses or rejection, making them a preferred choice for procedures requiring long-term tissue repair. Their seamless integration with the body ensures consistent demand and establishes them as a reliable solution in surgical applications.

The market is also segmented by application, including neurosurgery, spinal surgery, trauma and accident repairs, post-surgical repair, and others. The neurosurgery segment is expected to register significant growth with a projected CAGR of 5.5%, reaching USD 155.9 million by 2034. The increasing prevalence of neurological disorders and age-related conditions, coupled with the growing frequency of neurosurgical procedures, is driving demand for highly durable and effective dura substitutes. These materials are indispensable for repairing dura mater, reinforcing their critical role in neurosurgical treatments.

The U.S. Dura substitutes market, valued at USD 77 million in 2024, is forecasted to grow at a CAGR of 5% through 2034. The country's advanced healthcare infrastructure, combined with ongoing innovations in neurosurgical methods, including minimally invasive techniques, is fueling the adoption of high-performance, biocompatible substitutes. These advancements are enabling improved surgical outcomes and faster patient recovery, further supporting market expansion in the region.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of neurological disorders
      • 3.2.1.2 Advancements in surgical techniques
      • 3.2.1.3 Increasing surgical awareness and adoption
      • 3.2.1.4 Rising demand for minimally invasive procedures
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of dura substitutes
      • 3.2.2.2 Limited product availability in emerging markets
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
  • 3.6 Gap analysis
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis
  • 3.9 Future market trends
  • 3.10 Value chain analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Biological dura substitute
  • 5.3 Synthetic dura substitute

Chapter 6 Market Estimates and Forecast, By Material, 2021 – 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Collagen-based
  • 6.3 Polymers
  • 6.4 Other materials

Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Neurosurgery
  • 7.3 Spinal surgery
  • 7.4 Trauma/accident
  • 7.5 Post-surgical repair
  • 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Ambulatory surgical centers
  • 8.4 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 ACERA SURGICAL
  • 10.2 B. Braun
  • 10.3 Baxter
  • 10.4 Bennett
  • 10.5 Biosynth
  • 10.6 Cook Medical
  • 10.7 DePuy Synthes
  • 10.8 GUNZE
  • 10.9 INTEGRA
  • 10.10 Medprin
  • 10.11 Medtronic
  • 10.12 Natus
  • 10.13 Severn Healthcare Technologies
  • 10.14 Stryker
  • 10.15 GORE